| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |